Form 8-K - Current report:
SEC Accession No. 0001102624-13-000973
Filing Date
2013-08-12
Accepted
2013-08-12 08:01:22
Documents
2
Period of Report
2013-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucell8k.htm 8-K 4698
2 IMMUCELL CORPORATION PRESS RELEASE immucellcorporation.htm EX-99 5811
  Complete submission text file 0001102624-13-000973.txt   11599
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 131028211
SIC: 2835 In Vitro & In Vivo Diagnostic Substances